Balchem Corporation Schedules Key Conference Call
MONTVALE, N.J. — Balchem Corporation (NASDAQ: BCPC) has officially announced the date for its quarterly conference call, set for Thursday, July 31, 2025, at 11:00 AM Eastern Time. The call will provide an overview of the company’s financial performance for the second quarter of 2025, featuring insights from Ted Harris, the Chairman of the Board, President, and CEO, alongside Martin Bengtsson, the CFO.
What to Expect from the Conference Call
Before the call, Balchem is expected to release its second-quarter results, which will be made available on their website early that morning. Along with the results, the press release and accompanying financial exhibits will also be accessible. For live listeners, the conference call promises to enhance audio quality due to recent upgrades in their communication systems.
How to Join the Conference Call
Institutional investors, analysts, and those interested in the financial landscape are encouraged to join the live discussion. To do so, participants can dial 800-715-9871 for toll-free access in the USA and Canada, or +1-646-307-1963 for international queries. If you're calling from Canada, a specific line is available at 647-932-3411. It’s advisable to connect about five minutes prior to the anticipated start time of this important discussion.
Webcast Availability
For individuals who prefer a digital format, a live audio webcast of the conference call will also be available online. Simply visit the official Balchem webpage to join the call. After the conference ends, a replay will be readily accessible for those who couldn’t tune in live, ensuring that all stakeholders have the opportunity to stay updated on the company’s performance.
About Balchem Corporation
Founded with a mission to support the health and well-being of people and animals alike, Balchem Corporation develops, manufactures, and markets essential specialty ingredients. Their operations span several industries, reflecting a commitment to quality and innovation. The company meticulously categorizes its offerings into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Human Nutrition & Health Goals
The Human Nutrition & Health segment focuses on crafting customized ingredient systems that enhance food and beverages. These innovations deliver vital nutrients across several applications, supporting dietary needs in the food, supplement, and pharmaceutical sectors.
Animal Nutrition & Health Solutions
In the realm of Animal Nutrition & Health, Balchem provides specialized products catered to various markets. This includes solutions aimed at improving animal health, thereby addressing the growing global demand for sustainable and nutritious animal products.
Specialty Products Innovations
Through its Specialty Products division, Balchem markets specialized chemicals for healthcare and industry applications, in addition to supplying chelated minerals tailored for the agricultural micronutrient sector. This breadth of services solidifies Balchem’s role as a leader in enhancing life quality on a global scale.
Contact Information
If you have any inquiries regarding the upcoming conference call or the company’s operations, reach out to Jacqueline Yarmolowicz, Executive Assistant, at 845-326-5600 or via email at jyarmolowicz@balchem.com.
Frequently Asked Questions
1. When is the Balchem Corporation earnings call scheduled?
The earnings call is set for Thursday, July 31, 2025, at 11:00 AM Eastern Time.
2. How can I access the live webcast?
You can join the live audio webcast via Balchem's official website on the day of the conference call.
3. Who will be hosting the conference call?
Ted Harris, the Chairman of the Board, President, and CEO, along with CFO Martin Bengtsson will lead the call.
4. What segments does Balchem Corporation operate in?
Balchem operates in three key segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
5. Where can I find more about the company's financial results?
The financial results will be published on Balchem's website prior to the conference call on July 31, 2025.
